Suche

Programmdetails

Postervorträge

HFpEF: Hämodynamik, Kognition und Therapie

Freitag, 25. April | 09:45 - 10:45 Uhr | Posterbereich 19

Vorsitz/Chair: Christiane E. Angermann (Würzburg), Assem Aweimer (Bochum)

Agenda

(P976)
Cognitive deficits and microvascular brain alteration in patients with heart failure with preserved ejection fraction (HFpEF). Preliminary data of the HIM-Study
P. Müller (Magdeburg)
(P977)
Der CPET-HFpEF-Score: Ein neuer, nichtinvasiver Test zur Diagnose der Herzinsuffizienz mit erhaltener Ejektionsfraktion
T. Nitschke (Dortmund)
(P978)
Deceleration time and E/A show strongest association with declining estrogen levels as parameters for HFpEF definition in post-menopausal women
J. Weber (Düsseldorf)
(P979)
Glucagon-like Peptide 1 based treatments preserve left ventricular diastolic function - A systematic review and meta-analysis
I. M. Hecker (Jena)
(P980)
Increased PDE9 Oxidation Drives Elevated Diastolic Stiffness in HFpEF
S. Zhazykbayeva (Bochum)
(P981)
Efficacy and tolerability of SGLT2 Inhibitors in patients with pulmonary arterial hypertension and cardiovascular comorbidities
A. Florea (Heidelberg)
(P982)
Haemodynamic and Prognostic Implications of Pulmonary Artery Compliance in Patients with HFpEF and Normal Right Ventricular Function
A. Schulz (Göttingen)
(P984)
Effects of empagliflozin on cardiomyocyte function and mitochondrial respiration in a rat model of HFpEF: a focus on sex-specific responses
A. Nickel (Würzburg)
Diese Seite teilen